How new weight loss drugs will impact insurance premiums – Marketplace
The FDA has approved a new weight-loss drug, Eli Lillys Zepbound, sold under the name Mounjaro when it was only a diabetes drug. This is a new competitor to competitor Novo Nordisk’s very popular Wegovy injectable. Although these drugs can quickly help people lose weight, it is not yet clear… Continue Reading How new weight loss drugs will impact insurance premiums – Marketplace
